
|Articles|January 1, 2007
Will prostate cancer respond to metabolic-directed treatment?
Chicago-Findings from systematic research being conducted by researchers at the University of California, Davis suggest that arginine deprivation may be a novel treatment in some prostate cancers.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5















